Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Clinical Trial
Multiregional clinical trial data on FDA watch for U.S. applicability
By
LabPulse.com staff writers
Pivotal trials drawing on foreign clinical data in focus.
September 16, 2024
Qiagen ventures into chronic disease CDx
By
LabPulse.com staff writers
Qiagen has expanded its agreement with AstraZeneca beyond oncology.
August 29, 2024
Accelerate Diagnostics completes preclinical trial for antimicrobial test system
By
LabPulse.com staff writers
Accelerate Diagnostics successfully completed the preclinical trial of its WAVE antimicrobial susceptibility testing system.
August 12, 2024
Invenio enrolls 1st patients in AI-based lung cancer image analysis study
By
LabPulse.com staff writers
Invenio Imaging has begun enrolling patients in a pivotal study of its artificial intelligence (AI)-based image analysis module for lung cancer.
August 9, 2024
FDA stops BioNTech MediLink study due to 'significant risks,' adverse events
By
LabPulse.com staff writers
Conducted in both the U.S. and China, the YL202 study aimed to evaluate the safety and tolerability of the ADC as a later-line treatment for some cancers.
June 18, 2024
Immunovia announces positive results for next-gen pancreatic cancer test
By
LabPulse.com staff writers
Diagnostics company Immunovia announced positive results for the newest generation of its pancreatic cancer test from a model-development study, announcing that the test achieved both its primary and secondary endpoints.
April 25, 2024
Castle Biosciences shares melanoma test study data at SSO 2024
By
LabPulse.com staff writers
Castle Biosciences shared data from two studies on the performance of its DecisionDx-Melanoma test in patients with cutaneous melanoma at the Society of Surgical Oncology 2024 (SSO 2024) annual meeting, held March 20-23 in Atlanta.
March 26, 2024
ChromaCode partners with the Medical College of Georgia on NSCLC assay validation
By
LabPulse.com staff writers
ChromaCode announced a partnership with the Medical College of Georgia to test the analytical and clinical performance of ChromaCode's HDPCR non-small cell lung cancer (NSCLC) biomarker assay.
March 21, 2024
Novartis presents first results of SMART spinal muscular atrophy study
By
LabPulse.com staff writers
Company presents new data from a clinical study, called the SMART study, of its gene therapy in previously treated patients and a broader patient population.
March 5, 2024
‘Remarkable’ results in lupus patients spark speculation CAR-T may cure autoimmunity
By
Nick Paul Taylor
The generation of “remarkable” results in lupus patients has sparked speculation about the potential for chimeric antigen receptor T-cell (CAR-T cell) therapy to cure autoimmune diseases.
February 23, 2024
U.K. trial for mRNA-based cancer therapy begins
By
Matt Limb
Cancer patients in the U.K. are receiving an experimental mRNA therapy designed to help their bodies recognize and fight cancer cells.
February 7, 2024
Sensorion receives clinical trial approval for congenital deafness gene therapy
By
LabPulse.com staff writers
French biotech firm Sensorion has received approval to initiate a phase I and II clinical trial in France of SENS-501 (the OTOF-GT program), its gene therapy for gene-mediated hearing impairment.
January 22, 2024
Page 1 of 18
Next Page
